SPC-180002
SPC-180002 is a SIRT1/3 dual inhibitor, with IC50 values of 1.13 and 5.41 μM, respectively. SPC-180002 disturbs redox homeostasis via ROS generation, which leads to an increase in both p21 protein stability and mitochondrial dysfunction. SPC-180002 strongly inhibits cell cycle progression and cancer cell growth. SPC-180002 activates the Nrf2 signaling pathway.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2170274-53-8
- Fòrmula: C18H23NO4
- Peso molecular:317.38
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
|
SIRT1 1.13 ± 0.3 μM (IC50) |
SIRT3 5.41 ± 4.8 μM (IC50) |
In Vitro
SPC-180002 (0-5 μM, 24 h) inhibits cell cycle progression via p21 accumulation, which causes subsequent cellular senescence[1].
SPC-180002 dose not induce apoptosis and autophagy[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Five weeks female athymic nude mice (BALB/c)[1]
-
Dosage:1 mg/kg or 5 mg/kg
-
Administration:i.p., twice a week
-
Result:Significantly impeded tumor progression. The gain of tumor volume in SPC-180002-treated mice was significantly reduced by 48% at the low dose (1 mg/kg) and by 52% at the high dose (5 mg/kg), compared to vehicle-treated mice.
Chemical Information
-
No. CAS 2170274-53-8
-
Peso molecular 317.38
-
Fòrmula C18H23NO4
-
SMILES
O=C(C(CN(CCC1=CC=CC=C1)CC(C(OC)=O)=C)=C)OC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)